Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 14 Neoplasms 6 Colonic Neoplasms 5 Agnosia 5 Lung Neoplasms 4 Head and Neck Neoplasms 4 Cancer Pain 4 Breast Neoplasms 4 Rectal Neoplasms 3 Prostatic Neoplasms 3 Pain, Postoperative 3 Urinary Bladder Neoplasms 2 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pleural Effusion, Malignant 2 Pancreatic Neoplasms 2 Lymphoma, Follicular 2 Diverticulosis, Colonic 2 Chronic Pain 2 Breakthrough Pain 2 post laminectomy syndrome 1 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Thrombocythemia, Essential 1 Terminal Cancer 1 Sezary Syndrome 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1

Interventions

Radiosurgery 114 Temozolomide 104 Bevacizumab 71 Radiotherapy 67 Magnetic Resonance Spectroscopy 67 Carboplatin 29 pembrolizumab 28 Irinotecan 26 Surgical Procedures, Operative 25 Radiation 23 Nivolumab 23 Etoposide 22 Magnetic Resonance Imaging 21 Ipilimumab 21 Erlotinib Hydrochloride 21 Cyclophosphamide 21 Surveys and Questionnaires 19 Aminolevulinic Acid 18 Specimen Handling 16 Pemetrexed 16 Mental Status and Dementia Tests 16 Cisplatin 16 Carmustine 15 Topotecan 14 Trastuzumab 13 Saline Solution 12 Neuropsychological Tests 12 Gefitinib 11 Filgrastim 11 Drug Therapy 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Brain Neoplasms × Fentanyl × Clear all

NCT07165262 2025-09-10

ECOG-Anaes

Children's Cancer Hospital Egypt 57357

Phase 3 Active not recruiting

Brain Neoplasms, Epilepsy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡